Intrathecal dexmedetomidine as adjuvants to bupivacaine in cesarean sections

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14005227

Enrollment

Unknown

Registered

2014-09-11

Start date

2014-09-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

dexmedetomidine group:intrathecal dexmedetomidine

morphine group:intrathecal morphine

control group:intrathecal morphine

Eligibility

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: elective cesarean section, 20-40 years old, ASA I to II, 150-170cm height, single birth, full term partum

Exclusion criteria

Exclusion criteria: Obstetric complications, obesity, spinal anesthesia contraindications, multiple pregnancies, local anesthetics allergies

Design outcomes

Primary

Measure	Time frame
VAS scores;	—

Secondary

Measure	Time frame
onset and regression time of anesthesi;adverse effect;	—

Countries

China

Contacts

Public ContactQi Xiaofei

qixiaofeidoctor@163.com+86 13925275491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026